Kuo-Ping Chiu | Excellence in Innovation | Biological Networks

Published on by Network Science

Excellence in Innovation


Kuo-Ping Chiu
Top Science Biotechnologies, Inc.

Kuo-Ping Chiu is a researcher affiliated with Top Science Biotechnologies, Inc., Taiwan, whose scholarly profile is associated with the study of Biological Networks. His academic record includes 64 indexed documents, 20,457 citations, and an h-index of 25, indicating sustained scholarly activity and measurable visibility within the research literature.

Kuo-Ping Chiu
Affiliation Top Science Biotechnologies, Inc.
Country Taiwan
scholar id mJtuDY0AAAAJ
Documents 64
Citations 20,457
h-index 25
Subject Area Biological Networks
Event International Research Awards on Network Science & Graph Analytics

Abstract

Excellence in Innovation recognizes research activity that contributes to the advancement of scientific knowledge through rigorous investigation, methodological development, and application of emerging concepts. Kuo-Ping Chiu, affiliated with Top Science Biotechnologies, Inc. in Taiwan, has an academic profile connected with Biological Networks and network-oriented biological research. The reported scholarly record comprises 64 documents, 20,457 citations, and an h-index of 25. These indicators provide a quantitative context for evaluating research visibility, while the broader assessment of innovation should also consider methodological originality, reproducibility, interdisciplinary relevance, and contribution to scientific practice. [1]

Keywords

Biological Networks, Network Science, Graph Analytics, Systems Biology, Molecular Networks, Biological Data, Network Modeling, Graph Theory, Computational Biology, Research Innovation.

Introduction

Biological networks provide mathematical and computational representations of relationships among biological entities, including genes, proteins, metabolites, organisms, and regulatory components. Network science offers a framework for studying the organization, connectivity, dynamics, and emergent properties of such systems. Foundational work on complex networks established the importance of network topology and characteristic structural properties in understanding interconnected systems. [2] Subsequent research has demonstrated that network-based approaches can support the investigation of biological organization at multiple scales. [3]

Research Profile

Kuo-Ping Chiu’s reported research profile is situated within Biological Networks, an interdisciplinary area combining computational biology, graph-based reasoning, biological data interpretation, and systems-level investigation. The profile supplied for this article records 64 documents and 20,457 citations, with an h-index of 25. Citation-based indicators can provide useful evidence of scholarly reach, although they should be interpreted alongside publication quality, authorship contribution, research originality, and field-specific citation practices. [1]

  • Research orientation in Biological Networks and network-based biological investigation.
  • Integration of computational and network-oriented approaches for biological research.
  • Scholarly activity represented by 64 reported documents.
  • Reported citation impact of 20,457 citations and an h-index of 25.

Research Contributions

Research in Biological Networks can contribute to understanding biological systems by representing complex relationships as nodes and edges and subsequently examining their topology, connectivity, centrality, communities, and functional associations. Such approaches can complement conventional experimental methods by providing system-level perspectives on biological organization. The significance of individual contributions should ultimately be evaluated from the underlying publications, datasets, methods, validation procedures, and documented scientific outcomes rather than citation counts alone. [2]

  • Application of network concepts to the representation of biological relationships.
  • Use of graph-based perspectives for examining interconnected biological systems.
  • Potential integration of computational network analysis with biological interpretation.
  • Contribution to interdisciplinary research connecting biological science and network science.

Publications

The supplied profile reports 64 scholarly documents for Kuo-Ping Chiu. Because individual publication titles, journal information, publication years, and DOI identifiers were not supplied as part of the source data, this article does not assign specific publications to the researcher without verification. A complete bibliographic assessment should consult the researcher’s indexed publication record and distinguish original research articles, reviews, conference contributions, datasets, and other scholarly outputs. [1]

Research Impact

The reported 20,457 citations and h-index of 25 indicate substantial bibliometric visibility for the supplied academic profile. Citation measures, however, are descriptive indicators rather than complete measures of research quality or societal impact. In Biological Networks, research influence may additionally be reflected through methodological adoption, reuse of computational resources, interdisciplinary collaboration, contributions to biological interpretation, and subsequent development of network-based research. [1]

Award Suitability

Kuo-Ping Chiu’s documented affiliation, research subject area, publication activity, and reported bibliometric indicators provide a relevant basis for consideration within the International Research Awards on Network Science & Graph Analytics. His association with Biological Networks aligns conceptually with the application of network and graph methodologies to complex biological systems. Final award suitability should be determined through the event’s formal evaluation process, including verification of publications, research originality, documented contributions, academic credentials, and supporting evidence.

  • Alignment with the Biological Networks research domain.
  • Substantial reported scholarly publication and citation activity.
  • Relevance to network-based approaches in biological research.
  • Potential interdisciplinary significance across network science and computational biology.

Conclusion

Kuo-Ping Chiu’s profile presents a sustained record of scholarly activity in a research environment associated with Biological Networks. The reported 64 documents, 20,457 citations, and h-index of 25 provide measurable indicators of academic visibility. [1]

Within the context of the International Research Awards on Network Science & Graph Analytics, the profile is relevant for consideration because biological network research applies network concepts to complex scientific systems. Recognition should remain evidence-based and subject to independent assessment of the researcher’s verified contributions.

References

  1. Elsevier. (n.d.). Scholar: Abstract and citation database. Scholar .https://scholar.google.com/citations?user=mJtuDY0AAAAJ&hl=en&oi=sra
  2. Watts, D. J., & Strogatz, S. H. (1998). Collective dynamics of “small-world” networks. Nature, 393, 440–442.DOI:
    https://doi.org/10.1038/30918
  3. Barabási, A.-L., & Albert, R. (1999). Emergence of scaling in random networks. Science, 286(5439), 509–512.DOI:
    https://doi.org/10.1126/science.286.5439.509

 

Anastasia Bougea | Biological Networks | Innovative Research Award

Published on by Network Science

Innovative Research Award

Anastasia Bougea
National and Kapodistrian University of Athens

Anastasia Bougea
Affiliation National and Kapodistrian University of Athens
Country Greece
Scopus ID 55629725400
Documents 136
Citations 2352
h-index 27
Subject Area Biological Networks
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0003-3006-8711

Anastasia Bougea is a Greek researcher affiliated with the National and Kapodistrian University of Athens whose scholarly work spans neurology, neurodegenerative diseases, clinical neuroscience, digital health, and data-driven approaches to understanding complex biological systems. Her publication record demonstrates sustained contributions to Parkinson’s disease, dementia-related disorders, neuropsychological assessment, and emerging machine-learning methodologies in healthcare research.[1] Through interdisciplinary investigations integrating clinical evidence, neurological biomarkers, and computational analysis, her research aligns with contemporary developments in biological network science and translational medicine.[2]

Abstract

This article summarizes the academic profile of Anastasia Bougea and evaluates her suitability for recognition through the Innovative Research Award. Her body of work reflects a multidisciplinary approach linking neurological disorders, clinical diagnostics, machine learning, mobile health technologies, and molecular mechanisms of neurodegeneration. The scope and continuity of her contributions indicate an active engagement with contemporary biomedical challenges and network-oriented approaches to disease understanding.[3]

Keywords

Biological Networks, Neurodegenerative Diseases, Parkinson’s Disease, Machine Learning, Clinical Neuroscience, Mobile Health, Dementia, Alpha-Synuclein, Biomarkers, Graph Analytics.

Introduction

Research into neurodegenerative diseases increasingly relies on interconnected biological data, computational modeling, and predictive analytics. Anastasia Bougea’s scholarly activities contribute to this evolving landscape through studies addressing disease mechanisms, clinical assessment tools, and technology-assisted healthcare solutions. Her work demonstrates the integration of biomedical knowledge with analytical methods relevant to modern network science applications.[4]

Research Profile

With 136 indexed publications, 2,352 citations, and an h-index of 27, Bougea has established a substantial academic presence. Her research portfolio encompasses Parkinson’s disease, dementia with Lewy bodies, frontotemporal dementia, non-coding RNA therapeutics, and digital health technologies. Her publication activity reflects sustained engagement with peer-reviewed international journals and collaborative research initiatives.[1]

Research Contributions

  • Applied machine learning techniques for predicting multiple system atrophy and progressive supranuclear palsy.
  • Investigated therapeutic opportunities involving non-coding RNAs in neurodegenerative diseases.
  • Reviewed molecular pathways associated with alpha-synuclein and GBA1-related neurological disorders.
  • Explored mobile health technologies supporting Parkinson’s disease management.

Publications

  • Machine learning-based prediction of multiple system atrophy and progressive supranuclear palsy using clinical and neuropsychological scores (2026).
  • Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases (2026).
  • Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review (2026).
  • Underlying Mechanisms of GBA1 in Parkinson’s Disease and Dementia with Lewy Bodies (2025).
  • Mobile Health Technologies for the Management of Parkinson’s Disease (2025).

Research Impact

The impact of Bougea’s research is reflected through citation activity, interdisciplinary relevance, and practical implications for neurological healthcare. Her studies support improved understanding of disease progression, digital monitoring technologies, and predictive clinical tools. These contributions help bridge translational research with patient-centered applications and data-driven decision-making frameworks.[5]

Award Suitability

Anastasia Bougea demonstrates characteristics commonly associated with innovative research recognition, including interdisciplinary scholarship, measurable scientific impact, and continued publication productivity. Her integration of machine learning, molecular neuroscience, and mobile health technologies contributes to emerging approaches within biological networks and graph-informed biomedical analysis. These achievements provide a strong basis for consideration within the International Research Awards on Network Science & Graph Analytics.[6]

Conclusion

Bougea’s academic record reflects sustained contributions to neuroscience and neurodegenerative disease research. Her work combines clinical relevance with analytical innovation, supporting advancements in predictive medicine and network-based biomedical understanding. The breadth of her scholarly output and demonstrated impact support recognition within an international research award framework.

References

  1. Elsevier. (n.d.). Scopus author details: Anastasia Bougea, Author ID 55629725400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55629725400
  2. Bougea, A. (2026). Machine learning-based prediction of multiple system atrophy and progressive supranuclear palsy using clinical and neuropsychological scores.
    DOI: https://doi.org/10.1016/j.bnd.2026.02.002
  3. Bougea, A. (2026). Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases.
    DOI: https://doi.org/10.3390/ijms27073260
  4. Bougea, A. (2026). Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review.
    DOI: https://doi.org/10.3390/cells15050470
  5. Bougea, A. (2025). Underlying Mechanisms of GBA1 in Parkinson’s Disease and Dementia with Lewy Bodies.
    DOI: https://doi.org/10.3390/genes16121496
  6. Bougea, A. (2025). Mobile Health Technologies for the Management of Parkinson’s Disease.
    DOI: https://doi.org/10.1080/14737175.2025.2580468

Vipin Yadav | Biological Networks | Best Paper Award

Published on by Network Science

Best Paper Award

Vipin Yadav
Moffitt Cancer Center, United States

Vipin Yadav
Affiliation Moffitt Cancer Center
Country United States
Scopus ID 57210883410
Documents 11
Citations 54
h-index 5
Subject Area Biological Networks
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0001-9862-5233

Vipin Yadav is a researcher affiliated with Moffitt Cancer Center whose scholarly work spans cancer biology, immunotherapy, molecular oncology, and biological network analysis. His publications demonstrate a focus on understanding complex cellular interactions, signaling mechanisms, and therapeutic interventions relevant to melanoma and related malignancies. Through contributions involving translational research and emerging biomedical technologies, Yadav has participated in advancing scientific understanding of biological systems and network-driven disease mechanisms. His publication record and citation impact reflect active engagement in contemporary biomedical research and support consideration for recognition within the field of Biological Networks.[1]

Abstract

This article evaluates the academic profile of Vipin Yadav in relation to the Best Paper Award category. His research activities emphasize cancer immunology, molecular mechanisms of melanoma progression, therapeutic response pathways, and innovative biomedical interventions. Recent publications demonstrate engagement with clinically relevant topics including mRNA-lipid nanoparticle CAR-T technologies, immunogenic cell death, and molecular determinants of treatment sensitivity. These contributions reflect interdisciplinary research linking biological networks with translational medicine and cancer therapeutics.[2]

Keywords

Biological Networks, Cancer Research, Melanoma, Immunotherapy, CAR-T Cells, Translational Medicine, Molecular Oncology, Network Science.

Introduction

Modern biomedical research increasingly relies on network-based approaches to understand disease progression and therapeutic response. Researchers investigating cellular signaling, immune interactions, and genomic regulation contribute significantly to biological network science. Within this context, Vipin Yadav’s work addresses molecular and cellular processes associated with cancer biology, offering insights that support both scientific understanding and clinical translation.[3]

Research Profile

According to available scholarly metrics, Yadav has authored multiple peer-reviewed publications, accumulating citations across oncology and biomedical science disciplines. His research portfolio demonstrates participation in studies involving melanoma biology, immune modulation, cell death mechanisms, and emerging therapeutic platforms. The combination of publication activity, citation performance, and interdisciplinary collaboration indicates an active contribution to contemporary cancer research.[1]

Research Contributions

  • Investigation of immunogenic cell death pathways in NRAS-mutant melanoma.
  • Research on nitrosylation mechanisms affecting therapeutic responses.
  • Contributions to mRNA-lipid nanoparticle CAR-T cell engineering and clinical translation.
  • Studies examining DNA damage mechanisms and delayed CPD formation.
  • Integration of molecular biology and biological network perspectives in cancer research.

Publications

  • In Vivo mRNA-Lipid Nanoparticle CAR-T Cell Engineering: Advances, Challenges, and Clinical Translation (2026).
  • Melanin-Driven Delayed CPD Formation Is Independent of Melanin Biosynthesis Pathway (2025).
  • Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors (2025).

Research Impact

The impact of Yadav’s research is reflected through citation activity, publication in established journals, and relevance to translational oncology. His investigations address clinically significant questions concerning immune responses, targeted therapies, and cancer treatment resistance. Such research contributes to the broader scientific effort to improve therapeutic outcomes and expand understanding of complex biological interaction networks.[4]

Award Suitability

Vipin Yadav demonstrates characteristics commonly associated with Best Paper Award consideration, including publication in recognized scientific journals, engagement with innovative biomedical technologies, and contributions to biologically relevant network research. His recent scholarly outputs address significant challenges in oncology and immunotherapy while maintaining relevance to network-driven analyses of disease processes. The quality and topical importance of these contributions support recognition within the International Research Awards on Network Science & Graph Analytics framework.[5]

Conclusion

Vipin Yadav’s academic record reflects sustained involvement in cancer biology, molecular research, and translational medicine. Through publications addressing melanoma, immunotherapy, and emerging therapeutic technologies, he contributes to the advancement of biological network understanding. Based on available scholarly indicators and research outputs, his profile aligns with the objectives of recognizing impactful scientific research through the Best Paper Award category.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Vipin Yadav, Author ID 57210883410. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57210883410
  2. Biomedicines. (2026). In Vivo mRNA-Lipid Nanoparticle CAR-T Cell Engineering: Advances, Challenges, and Clinical Translation.
    https://doi.org/10.3390/biomedicines14061276
  3. Journal of Investigative Dermatology. (2025). Melanin-Driven Delayed CPD Formation Is Independent of Melanin Biosynthesis Pathway.
    https://doi.org/10.1016/j.jid.2025.09.011
  4. Cancer Research. (2025). Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors.
    https://doi.org/10.1158/0008-5472.CAN-24-0693
  5. ORCID. (n.d.). Researcher Profile: Vipin Yadav.
    https://orcid.org/0000-0001-9862-5233
  6. International Research Awards on Network Science & Graph Analytics. (n.d.). Award Program Information.
    networkscience-conferences.researchw.com

Seung Beom Seo | Biological Networks | Research Excellence Award

Published on by Network Science

Prof. Seung Beom Seo | Biological Networks | Research Excellence Award

University of Seoul | South Korea

Prof. Seung Beom Seo is an Associate Professor at the International School of Urban Science, University of Seoul, where he also serves as Head of the Department of Sustainable Urban Development and Director of the Global Urban and Infrastructure Research Center. He earned his PhD in Civil Engineering from North Carolina State University, USA, following his master’s degree from Seoul National University and a bachelor’s degree from Dongguk University, South Korea. Prof. Seo’s academic career includes roles as Assistant Professor at the University of Seoul, Research Fellow at the Korea Environment Institute, and Post-doctoral Researcher at Seoul National University. He began his professional journey as an Engineer at Daewoo E&C. His research interests focus on Biological Networks, with particular emphasis on Biological Connectivity.

Citation Metrics (Scopus)

500
200
100
50
0

Citations
467

Documents
48

h-index
11

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile
 View Google Scholar Profile

Featured Publications

Biological Connectivity in Freshwater Ecosystems: Evaluation of Spatial and Temporal Anomalies in a River Basin

– Ecohydrology, 2025
An Integrated Approach for Characterizing and Selecting Climate Change Scenarios Based on Variability and Extremeness

– Scientific Reports, 2025
Development of a Flood Damage Mitigation Index for Flood Management Capacity Assessment Using Regression Function Parameters

– Natural Hazards, 2025
Effects of Flood Mitigation Policies under Climate Change Scenarios Based on the Cost-Benefit Perspective in the Mountainous Korean Basin

– Natural Hazards, 2025

Fatemeh Safari | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Fatemeh Safari | Biological Networks | Best Researcher Award

Assistant Professor at Shiraz University of Medical Sciences, Iran📖

Dr. Fatemeh Safari is an Assistant Professor at the Diagnostic Laboratory Science and Technology Research Center, Shiraz University of Medical Sciences, Iran. She holds a PhD in Medical Biotechnology from Tabriz University of Medical Sciences, where she also completed her MSc in the same field. Her academic journey began with a BSc in Nursing from Shiraz University of Medical Sciences. With expertise in genome editing, cell culture, and protein biochemistry, Dr. Safari has contributed significantly to the field of biotechnology, specializing in gene expression regulation and improving recombinant CHO cell productivity.

Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

Education Background🎓

  • PhD in Medical Biotechnology
    Tabriz University of Medical Sciences, Tabriz, Iran (2015-2021)
  • MSc in Medical Biotechnology
    Tabriz University of Medical Sciences, Tabriz, Iran (2010-2013)
    Top student in the program, elected student by the organization for Gifted and Talented Education
  • BSc in Nursing
    Shiraz University of Medical Sciences, Shiraz, Iran (2001-2004)
    Elected student by the organization for Gifted and Talented Education

Professional Experience🌱

  • Assistant Professor, Diagnostic Laboratory Science and Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (2024–Present)
    In charge of the cell culture room, designing and implementing research projects, and mentoring MSc and Ph.D. students.
  • Senior Researcher, Diagnostic Laboratory Science and Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (2020–2023)
    Led research in genome editing, cell culture, and protein biochemistry techniques.
  • Laboratory Assistant, R&D Applied Drug Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (2013–2014)
    Gained hands-on experience in animal studies, cell culture, and immunization techniques.
  • Emergency Medical Technician, EMS and Disaster Management Center, Shiraz, Fars, Iran (2005–2013)
    Trained in resuscitation and participated in disaster and emergency medical events.
Research Interests🔬

Dr. Safari’s research primarily focuses on genome editing using the CRISPR/Cas9 system, regulation of gene expression, and the enhancement of CHO cell productivity. She is also dedicated to advancing protein expression and purification techniques, particularly in the fields of molecular cloning and cell-based assays. Furthermore, Dr. Safari investigates small animal models and stem cell culture for therapeutic applications.

Author Metrics

Dr. Safari has contributed to multiple research projects and publications in the field of medical biotechnology. Her work in CRISPR gene editing and cell culture technologies has been widely recognized, and she actively participates in academic workshops on molecular biology and biotechnology techniques. Her teaching experience includes mentoring graduate and Ph.D. students, and she is an expert in advanced laboratory techniques and molecular cellular biology.

Publications Top Notes 📄

1. CRISPR Cpf1 Proteins: Structure, Function, and Implications for Genome Editing

  • Authors: F. Safari, K. Zare, M. Negahdaripour, M. Barekati-Mowahed, Y. Ghasemi
  • Journal: Cell & Bioscience
  • Volume: 9
  • Pages: 1-21
  • Year: 2019
  • Citations: 198
  • Summary: This paper explores the CRISPR/Cpf1 system, a novel genome-editing tool, and its applications in genetic engineering. It provides an in-depth look at the structure and functions of the Cpf1 protein and its potential advantages over other CRISPR systems like Cas9.

2. Overview of Albumin and Its Purification Methods

  • Authors: R. Raoufinia, A. Mota, N. Keyhanvar, F. Safari, S. Shamekhi, J. Abdolalizadeh
  • Journal: Advanced Pharmaceutical Bulletin
  • Volume: 6
  • Issue: 4
  • Pages: 495
  • Year: 2016
  • Citations: 165
  • Summary: This review covers the properties of albumin, a critical protein in pharmaceutical and medical applications, and discusses various techniques for its purification, emphasizing its importance in therapeutic use.

3. Immunotoxins in Cancer Therapy: Review and Update

  • Authors: B. Akbari, S. Farajnia, S. Ahdi Khosroshahi, F. Safari, M. Yousefi, …
  • Journal: International Reviews of Immunology
  • Volume: 36
  • Issue: 4
  • Pages: 207-219
  • Year: 2017
  • Citations: 149
  • Summary: This paper provides an overview of immunotoxins and their evolving role in cancer immunotherapy. It reviews the latest developments in immunotoxin-based treatments, which combine targeted antibody therapy with toxic agents to destroy cancer cells.

4. CRISPR System: A High-Throughput Toolbox for Research and Treatment of Parkinson’s Disease

  • Authors: F. Safari, G. Hatam, A.B. Behbahani, V. Rezaei, M. Barekati-Mowahed, …
  • Journal: Cellular and Molecular Neurobiology
  • Volume: 40
  • Pages: 477-493
  • Year: 2020
  • Citations: 65
  • Summary: This article reviews the use of the CRISPR/Cas9 gene-editing system in the context of Parkinson’s disease research and therapy. It highlights high-throughput methods for studying the disease and potential CRISPR-based treatments.

5. CRISPR and Personalized Treg Therapy: New Insights into the Treatment of Rheumatoid Arthritis

  • Authors: F. Safari, S. Farajnia, M. Arya, H. Zarredar, A. Nasrolahi
  • Journal: Immunopharmacology and Immunotoxicology
  • Volume: 40
  • Issue: 3
  • Pages: 201-211
  • Year: 2018
  • Citations: 65
  • Summary: This review discusses the role of regulatory T cells (Tregs) in the immune system and how CRISPR-based technologies can be used for personalized therapies to treat autoimmune diseases, particularly rheumatoid arthritis.

Conclusion

Dr. Fatemeh Safari is a highly deserving candidate for the Best Researcher Award, given her groundbreaking contributions to medical biotechnology, particularly in genome editing, cell culture, and protein biochemistry. Her research in CRISPR/Cas9 technology, its applications in disease treatment, and her dedication to teaching and mentoring future scientists are noteworthy. While there are opportunities for her to expand the practical applications and international reach of her work, her academic and research achievements already place her at the forefront of her field. The recognition through the Best Researcher Award would not only honor her past achievements but also serve as a platform for the next stage of her career, allowing her to make even greater strides in biotechnology and medical research.